Stryker Corporation (SYK)
NYSE • Healthcare
August 18, 2026 at 20:00 UTC
About Stryker Corporation
Stryker Corporation (NYSE: SYK) makes medical devices for orthopaedic, surgical, neurotechnology, and emergency-care settings. In healthcare, it sells implants for joint replacement procedures, trauma and extremity products, spinal systems, and hospital equipment, and it recorded $25.1 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Stryker Corporation's Technical Indicators Summary
SYK shows a mixture of mildly negative short-term momentum and weak directional conviction, which helps explain the neutral stance. Short-term moving averages sit above the current price around 331, indicating recent underperformance while medium-term 50/100-day averages remain supportive, and the 200-day average is higher still, producing a layered picture. Momentum readings are slightly negative and RSI is near the middle, while ADX is low, signaling a lack of a strong trend. Volume-derived OBV is materially negative and ATR is moderate, adding caution around moves. Technical takeaway: Neutral.
| Indicator | Value |
|---|---|
RSI (14) | 48.31 |
Stochastic %K (14, 3, 3) | 47.61 |
CCI (20) | -24.19 |
WPR (14) | -59.40 |
Momentum (10) | -4.59 |
MFI | 22.65 |
MACD Level (12, 26) | 3.58 |
Bollinger Bands | $315.99 - $358.30 |
ATR (14) | $9.96 (3.00%) |
ADX (14) | 10.61 |
OBV | -19,332,485 |
Classic Pivot Point | $334.25 |
Fibonacci Pivot Point | $334.25 |
Exponential Moving Averages | $329.09 - $343.40(5 indicators) |
Simple Moving Averages | $321.17 - $340.92(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day wrapped with SYK just under water versus yesterday, after a tiny -0.09% gap. End-of-day, the peer group was modestly in the green at 1.59%, providing a small boost to sentiment. SYK faces potential downside as a holder plans to sell RSU shares vesting in 2026.
Trading Volume
Above 10d avg 2.1M
3M
vs S&P 500 Today
Outperforming Market
+0.51%
52-Week Position
Mid-range
43.5%
Updated: August 18, 2026 at 20:25 UTC
Quote Summary
SYK Headlines
Citi Resets Life Sciences And MedTech Views
March 11, 2026
Quiet Compounders Lead 2025’s Year-End Market Tone
January 1, 2026